Emory University’s Heron Therapeutics HRTX Stock Holding History

Emory University’s Portfolio HRTX Stock Details HRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-49,974	Closed	-$925K	–	7
2019 Q3	$925K	Sell	49,974 -79,046	-61%	-$1.45M	1.82%	12
2019 Q2	$2.4M	Buy	129,020 +42,543	+49%	+$850K	1.69%	21
2019 Q1	$2.11M	Buy	86,477 +2,212	+3%	+$57.9K	1.49%	31
2018 Q4	$2.19M	Buy	84,265 +14,425	+21%	+$397K	1.72%	16
2018 Q3	$2.21M	Sell	69,840 -14,635	-17%	-$545K	1.45%	30
2018 Q2	$3.28M	Buy	+84,475	New	+$2.69M	2.18%	5

Other funds holding HRTX

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Emory University's HRTX Position: Q4 2019 in Review

Emory University sold out of Heron Therapeutics (HRTX) in Q4 2019, closing a stake of 49,974 shares — an estimated $925K sold.

Emory University first reported a position in HRTX in Q2 2018 and held it in 6 quarters. The position peaked at $3.28M in Q2 2018. 199 funds tracked by Wall St. Rank hold HRTX as of Q4 2019.

Emory University reported no remaining Heron Therapeutics position as of Q4 2019 after selling out during the quarter.
Emory University sold 49,974 Heron Therapeutics shares in Q4 2019, an estimated $925K.
Emory University first reported a position in Heron Therapeutics in Q2 2018 and held it in 6 quarters.
Emory University's Heron Therapeutics position peaked at $3.28M in Q2 2018.
199 funds tracked by Wall St. Rank held Heron Therapeutics as of Q4 2019.

Based on Emory University's 13F filing for Q4 2019, filed 13 Feb 2020.